Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by mdjbrownon Feb 22, 2023 9:57am
250 Views
Post# 35298067

Anyone else getting the impression that all of the things

Anyone else getting the impression that all of the thingstaking place lately have been methodically timed for something much bigger where Medipharm is concerned.


Mr Pidducks deep connections in the pharma industry

Dr. Yasmine Hurds connection with Medipharm and her CBD reasearch as it relates to opioid addiction

The takeover of VIVO to be finalized in the first half of 2023 with shareholder approval

The timing of the HEXO appeal where more than $10 million will be owed to Medipharm.

The various Medipharm participation with cbd medical trials heading into phase 2 and 3

Very interesting times ahead me thinks

Big question outstanding near term is do the 57.5 million .70 cent warrants set to expire in less than 2 weeks on March 5, 2023 come into play somehow?  Even more interesting is March 5 is a Sunday which is very unusual.

Stay tuned......................

 https://canadianwarrants.com/price/current.htm#axzz7u3fSWnZT

<< Previous
Bullboard Posts
Next >>